General
TGA approves domestic production of AstraZeneca’s COVID-19 vaccine
Australia’s medical regulator has approved the domestic production of the Oxford-AstraZeneca COVID-19 vaccine, with the first batches expected to be released “in the next few days.”
Key points:
- The AstraZeneca vaccine will be manufactured at two sites in Melbourne
- Health Minister Greg Hunt said the approval was a “critical next step” in the national vaccination process
- Phase 1B of the national vaccine rollout begins on Monday
In a statement, the Therapeutic Goods Administration said the approval was granted “earlier today” and that it was a “critical and very exciting milestone” in Australia’s response to the pandemic.
“Specific approval of Australian manufacturing by TGA was required to ensure that the locally-manufactured vaccine had…
-
Business15 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
Business18 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
Noosa News9 hours agoSenior constable injured in crash between unmarked police car and stolen vehicle in Pimpama, Queensland
-
Business14 hours agoASX 200 mining shares rip as lithium makes a comeback